Financials
- Market Capitalization 22.96 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
13.29
Relación precio/flujo de caja
3.54
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 523 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.11 USD | +0.79% | -3.57% | +3.37% | +50.59% | 24.95 B USD | ||
| 538 | INSM Insmed Incorporated - Common Stock | 109.26 USD | -0.77% | -3.92% | +12.06% | -32.58% | 23.68 B USD | ||
| 565 | UTHR United Therapeutics Corporation - Common Stock | 532.41 USD | +1.09% | -2.92% | -3.80% | +80.33% | 22.60 B USD | ||
| 572 | BNTX BioNTech SE - American Depositary Shares | 90.35 USD | -0.06% | -2.39% | -0.42% | -17.93% | 21.68 B USD |